MedPath

FRUZAQLA

FRUZAQLA

Approved
DIN Number

02551454

Drug Class

Human

Market Date

Oct 30, 2024

Company
HC

takeda canada inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02551454
AIG Number0166184001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L01EK04 FRUQUINTINIB
Product Specifications
Dosage FormCapsule
Route of AdministrationOral
AHFS Classification10:00.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

FRUQUINTINIBActive
Strength: 1 MG
Monograph: FRUQUINTINIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.